China Health Technology Group Holding Company Limited (CHBOD)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0300 (150.00%)
At close: Apr 29, 2025
CHBOD Income Statement
Financials in millions CNY. Fiscal year is July - June.
Millions CNY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 59.7 | 47.61 | 58.72 | 6.76 | - | 6.67 | Upgrade | |
Revenue Growth (YoY) | 9.11% | -18.92% | 769.11% | - | - | -86.09% | Upgrade |
Cost of Revenue | 58.78 | 45.71 | 47.21 | 6.76 | - | - | Upgrade |
Gross Profit | 0.92 | 1.9 | 11.51 | - | - | 6.67 | Upgrade |
Selling, General & Admin | 23.4 | 22.89 | 19.92 | 11.71 | 21.44 | 48.98 | Upgrade |
Operating Expenses | 23.4 | 22.89 | 19.92 | 11.71 | 21.44 | 48.98 | Upgrade |
Operating Income | -22.48 | -21 | -8.41 | -11.71 | -21.44 | -42.31 | Upgrade |
Interest Expense | -4.52 | -3.23 | -11.68 | -21.22 | -22.52 | -20.79 | Upgrade |
Interest & Investment Income | 0 | 0 | 0.01 | 0 | 2.4 | 0.49 | Upgrade |
Currency Exchange Gain (Loss) | 0.3 | - | -34.57 | - | -0 | -6.54 | Upgrade |
Other Non Operating Income (Expenses) | -3.19 | -3.19 | 0.08 | 0.15 | 0.09 | -6.33 | Upgrade |
EBT Excluding Unusual Items | -29.88 | -27.41 | -54.57 | -32.78 | -41.48 | -75.48 | Upgrade |
Gain (Loss) on Sale of Assets | -0.3 | -0.3 | -0.08 | -0.13 | 0.04 | 0.43 | Upgrade |
Asset Writedown | 33.82 | 25.7 | 38.11 | 12.53 | -322.91 | -83.4 | Upgrade |
Other Unusual Items | - | 202.02 | 7.16 | - | - | - | Upgrade |
Pretax Income | 3.64 | 200.02 | -9.37 | -20.38 | -364.34 | -158.45 | Upgrade |
Income Tax Expense | 0.07 | 0.01 | 1.43 | - | - | - | Upgrade |
Earnings From Continuing Operations | 3.57 | 200.01 | -10.8 | -20.38 | -364.34 | -158.45 | Upgrade |
Earnings From Discontinued Operations | - | - | - | 1.48 | -4.74 | - | Upgrade |
Net Income to Company | 3.57 | 200.01 | -10.8 | -18.9 | -369.09 | -158.45 | Upgrade |
Net Income | 3.57 | 200.01 | -10.8 | -18.9 | -369.09 | -158.45 | Upgrade |
Net Income to Common | 3.57 | 200.01 | -10.8 | -18.9 | -369.09 | -158.45 | Upgrade |
Shares Outstanding (Basic) | 75 | 67 | 11 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 75 | 67 | 11 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | 104.45% | 509.04% | - | - | - | - | Upgrade |
EPS (Basic) | 0.05 | 2.98 | -0.98 | -1.71 | -33.48 | -14.37 | Upgrade |
EPS (Diluted) | 0.05 | 2.98 | -0.98 | -1.71 | -33.48 | -14.37 | Upgrade |
Free Cash Flow | 0.84 | 2.37 | 0.16 | -0.47 | 0.11 | -5.58 | Upgrade |
Free Cash Flow Per Share | 0.01 | 0.04 | 0.01 | -0.04 | 0.01 | -0.51 | Upgrade |
Gross Margin | 1.53% | 3.98% | 19.60% | - | - | 100.00% | Upgrade |
Operating Margin | -37.66% | -44.10% | -14.32% | -173.28% | - | -634.76% | Upgrade |
Profit Margin | 5.98% | 420.14% | -18.39% | -279.75% | - | -2377.02% | Upgrade |
Free Cash Flow Margin | 1.41% | 4.97% | 0.28% | -6.90% | - | -83.77% | Upgrade |
EBITDA | -22.17 | -20.74 | -8.4 | -11.7 | -21.38 | -42.15 | Upgrade |
EBITDA Margin | -37.14% | -43.56% | -14.30% | -173.10% | - | - | Upgrade |
D&A For EBITDA | 0.31 | 0.26 | 0.01 | 0.01 | 0.06 | 0.16 | Upgrade |
EBIT | -22.48 | -21 | -8.41 | -11.71 | -21.44 | -42.31 | Upgrade |
EBIT Margin | -37.66% | -44.10% | -14.32% | -173.28% | - | - | Upgrade |
Effective Tax Rate | 1.90% | 0.00% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.